Saha Priyanka, Talukdar Anupam Das, Nath Rajat, Sarker Satyajit D, Nahar Lutfun, Sahu Jagajjit, Choudhury Manabendra Dutta
Department of Life Science & Bioinformatics, Assam University, Silchar, India.
Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Front Pharmacol. 2019 May 24;10:509. doi: 10.3389/fphar.2019.00509. eCollection 2019.
The liver is not only involved in metabolism and detoxification, but also participate in innate immune function and thus exposed to frequent target Thus, they are the frequent target of physical injury. Interestingly, liver has the unique ability to regenerate and completely recoup from most acute, non-iterative situation. However, multiple conditions, including viral hepatitis, non-alcoholic fatty liver disease, long term alcohol abuse and chronic use of medications can cause persistent injury in which regenerative capacity eventually becomes dysfunctional resulting in hepatic scaring and cirrhosis. Despite the recent therapeutic advances and significant development of modern medicine, hepatic diseases remain a health problem worldwide. Thus, the search for the new therapeutic agents to treat liver disease is still in demand. Many synthetic drugs have been demonstrated to be strong radical scavengers, but they are also carcinogenic and cause liver damage. Present day various hepatic problems are encountered with number of synthetic and plant based drugs. Nexavar (sorafenib) is a chemotherapeutic medication used to treat advanced renal cell carcinoma associated with several side effects. There are a few effective varieties of herbal preparation like Liv-52, silymarin and Stronger neomin phages (SNMC) against hepatic complications. Plants are the huge repository of bioactive secondary metabolites viz; phenol, flavonoid, alkaloid etc. In this review we will try to present exclusive study on phenolics with its mode of action mitigating liver associated complications. And also its future prospects as new drug lead.
肝脏不仅参与新陈代谢和解毒,还参与先天免疫功能,因此频繁成为损伤的靶点。因此,它们是物理损伤的常见靶点。有趣的是,肝脏具有独特的再生能力,能够从大多数急性、非反复性的损伤情况中完全恢复。然而,多种情况,包括病毒性肝炎、非酒精性脂肪性肝病、长期酗酒和长期用药,可导致持续性损伤,最终再生能力功能失调,导致肝纤维化和肝硬化。尽管现代医学在治疗方面取得了最新进展且有了显著发展,但肝脏疾病仍然是全球范围内的一个健康问题。因此,寻找治疗肝脏疾病的新治疗药物仍然很有必要。许多合成药物已被证明是强大的自由基清除剂,但它们也具有致癌性并会导致肝损伤。如今,各种肝脏问题都与多种合成药物和植物性药物有关。多吉美(索拉非尼)是一种用于治疗晚期肾细胞癌的化疗药物,有多种副作用。有几种有效的草药制剂,如利肝隆、水飞蓟素和强力新明磺(SNMC),可对抗肝脏并发症。植物是生物活性次生代谢产物的巨大宝库,即酚类、黄酮类、生物碱等。在本综述中,我们将尝试对酚类物质减轻肝脏相关并发症的作用方式进行专门研究。以及其作为新药先导的未来前景。